ALIS for Nontuberculous Mycobacterial Lung Disease Finds Favor with FDA Committee
August 8th 2018The FDA’s Antimicrobial Drugs Advisory Committee voted 12 to 2 in favor of the safety and efficacy of ALIS (amikacin liposome inhalation suspension) for difficult-to-treat patients with nontuberculous mycobacterial lung disease.
Read More
Low HIV, Syphilis Screening for Adolescents with Pelvic Inflammatory Disease
July 24th 2018Researchers found that just 18.4% of young women diagnosed at pediatric emergency departments with pelvic inflammatory disease received HIV and syphilis screening, despite their higher risk for those sexually transmitted infections.
Read More
Algorithm Predicts Which Patients Will Benefit from Antidepressants
July 20th 2018The statistical algorithm incorporates data including age, depression severity, neuroticism, and cognitive control to decide which patients with depression are most likely to benefit from the antidepressant sertraline.
Read More